Skip to main content
Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
266.58
+4.59 (1.75%)
Nov 20, 2024, 4:00 PM EST - Market closed

Insulet Revenue

Insulet had revenue of $543.90M in the quarter ending September 30, 2024, with 25.70% growth. This brings the company's revenue in the last twelve months to $1.98B, up 27.42% year-over-year. In the year 2023, Insulet had annual revenue of $1.70B with 30.02% growth.

Revenue (ttm)
$1.98B
Revenue Growth
+27.42%
P/S Ratio
9.41
Revenue / Employee
$661,300
Employees
3,000
Market Cap
18.70B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.70B391.80M30.02%
Dec 31, 20221.31B206.50M18.79%
Dec 31, 20211.10B194.40M21.49%
Dec 31, 2020904.40M166.20M22.51%
Dec 31, 2019738.20M174.40M30.93%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molina Healthcare 37.54B
Teva Pharmaceutical 16.77B
Baxter International 15.06B
Labcorp Holdings 12.71B
Quest Diagnostics 9.54B
Hologic 3.99B
Align Technology 3.96B
The Cooper Companies 3.80B
Revenue Rankings

PODD News

More News